The Brennan Passons Foundation

(Reuters) — British drugmaker GlaxoSmithKline P.L.C. has agreed to pay $105 million to settle allegations by 44 U.S. states and the District of Columbia that it promoted its medicines for unapproved uses, several states attorneys general announced Wednesday.


Category: What's New

About the Author


Comments are closed.